Co-expression of CAV1 and E-cadherin reduces tumor formation by sequestering β-catenin in a plasma membrane complex and thereby downregulating β-catenin/Tcf/Lef transcriptional activity [36]. The gene discussed is CAV1; the disease is neoplasm.